Home circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
Article Open Access

circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway

  • Changpeng Sun EMAIL logo , Hongjun Guan , Jinjin Li and Yinfeng Gu
Published/Copyright: February 16, 2023
Download Article (PDF)
Open Medicine
From the journal Open Medicine Volume 18 Issue 1

Abstract

Non-small cell lung cancer (NSCLC) accounts for 80% of total lung cancers, which are the main killer of cancer-related death worldwide. Circular RNA (circRNA) has been found to modulate NSCLC development. However, the role of circ_0000376 in NSCLC development has been underreported. The present work showed that circ_0000376 and 3-phos-phoinositide-dependent protein kinase-1 (PDPK1) expression were dramatically increased, but miR-545-3p was decreased in NSCLC tissues and cells. circ_0000376 expression was closely associated with lymph node metastasis, tumor-node-metastasis stage, and tumor size of NSCLC patients. circ_0000376 knockdown repressed NSCLC cell proliferation, migration, invasion, and glutaminolysis but induced cell apoptosis. Additionally, miR-545-3p bound to circ_0000376, and circ_0000376 regulated cell phenotypes by associating with miR-545-3p. MiR-545-3p also participated in NSCLC cell proliferation, migration, invasion, apoptosis, and glutaminolysis by targeting PDPK1. Further, circ_0000376 absence repressed tumor formation in vivo. Collectively, circ_0000376 regulated NSCLC cell tumor properties by the miR-545-3p/PDPK1 axis, suggesting that circ_0000376 could be employed as a therapeutic target for NSCLC.

Keywords: NSCLC; circ_0000376; miR-545-3p; PDPK1

1 Introduction

Lung cancer ranks first in mortality in men and accounts for over 10% of total cancers globally [1,2]. More than 80% of lung carcinomas are identified as non-small cell lung cancer (NSCLC) [3]. Despite much progress in NSCLC treatment, the prognosis of NSCLC cases is poor [4]. The dysregulation of circular RNA (circRNA) has been considered as the leading cause of NSCLC progression [5], but the precise inner mechanism is still underreported. Therefore, a deep understanding of the pathogenesis of NSCLC will be pressing to seek reliable and effective therapeutic targets for the cancer.

CircRNA is a specific transcript that forms a continuous loop structure, featured by conservatism, stability, and specificity [6]. CircRNA commonly functions by serving as a sponge of microRNA (miRNA). Most notably, circRNA CDR1 contains over 70 complementary sites of miR-7 [7]. Previous data have indicated the potential of circRNA as a new clinical biomarker and potential target in various cancers [8]. CircRNA is also involved in various cancer development, such as gastric carcinoma [9], bladder carcinoma [10], ovarian cancer [11], and NSCLC [12]. circ_0000376 has been revealed to facilitate gastric cancer tumorigenesis [13]. Besides, Peng and his colleagues explained that circ_0000376 might be involved in breast cancer development by regulating miR-1285-3p [14]. circ_0000376 is one of the 16 upregulated circRNAs between NSCLC tissues and adjacent normal tissues [15]. But the role of circ_0000376 in NSCLC progression has not been fully revealed.

MiRNA is a highly conserved non-coding RNA that possesses nearly 20 nucleotides and controls gene expression through binding to its non-coding region [16]. An increasing number of studies have underlined the core role of miRNA in governing NSCLC progression [17,18]. For example, miRNA can simultaneously activate the Wnt/β-catenin pathway to regulate NSCLC cell metastasis [19]. MiRNA also regulates the sensitivity of NSCLC to chemotherapy [20] and radiotherapy [21]. As reported, miR-545-3p acted as a suppressor in the NSCLC process [22]. 3-Phos-phoinositide-dependent protein kinase-1 (PDPK1) belongs to the AGC serine/threonine kinase family [23]. PDPK1 can activate many downstream effectors and thereby facilitates cancer progression [24]. Moreover, PDPK1 participated in NSCLC cell proliferation and invasion [25].

As predicted, miR-545-3p concurrently contained the complementary sites of circ_0000376 and PDPK1. Thus, we hypothesized that circ_0000376 induced PDPK1 by binding to miR-545-3p to mediate NSCLC progression. However, the published data have not reported whether the circ_0000376/miR-545-3p/PDPK1 was involved in the development of NSCLC. The present work analyzed the effects of circ_0000376 on NSCLC cell tumor properties and explored whether circ_0000376 participated in NSCLC development through the miR-545-3p-dependent PDPK1.

2 Materials and methods

2.1 Specimen collection

NSCLC tissues (N = 30) and adjacent healthy lung tissues (N = 30) were collected from NSCLC sufferers at Jianhu Clinical Medical College of Yangzhou University. The obtained tissues were kept at −80°C. The subjects signed the written informed consent before operation. The Ethics Committee of Jianhu Clinical Medical College of Yangzhou University approved this study.

2.2 Cell purchase and culture

Procell (Wuhan, China) provided human bronchial epithelial cell line (16HBE), lung adenocarcinoma cell line (H522), and NSCLC cell line (A549). 16HBE and H522 cells were grown in RPMI-1640 (Procell), while A549 cells were cultured in Ham’s F12K (Procell) at 37°C in a humid incubator with 5% CO2. RPMI-1640 and Ham’s F12K were supplemented with 10% fetal bovine serum (FBS; Procell) and 1% penicillin/streptomycin (Procell).

2.3 Oligonucleotides synthesis and plasmid construction

Small interfering RNA against circ_0000376 (si-circ_0000376, 5′-TCCATATGAGAGTTGGATTCT-3′; si-circ_0000376#2 5′-TATCCATATGAGAGTTGGATT-3′), the small hairpin RNA against circ_0000376 (sh-circ_0000376), miR-545-3p mimic (5′-UCAGCAAACAUUUAUUGUGUGC-3′), miR-545-3p inhibitor (5′-GCACACAAUAAAUGUUUGCUGA-3′), the overexpression plasmid of PDPK1 (pc-PDPK1), and controls (si-NC, sh-NC, miR-NC, miRNA inhibitor-NC, and pc-NC) were provided by Ribobio Co., Ltd (Guangzhou, China). Cell transfection was performed using TurboFect reagent (Thermo Fisher, Waltham, MA, USA) based on the instruction of the manufacturer.

2.4 Quantitative real-time PCR (qRT-PCR) and RNA treatment

RNAsimple reagents (Tiangen, Beijing, China) were used for RNA extraction. RNA was incubated with RNase R (Xiyuan Biotechnology, Shanghai, China) to analyze circ_0000376 stability, regarding untreated cells as controls (mock). Reverse transcription was carried out using FastKing RT Kit (Tiangen) and MicroRNA RT reagents (Thermo Fisher). Then, FastFire qPCR PreMix (Tiangen) was utilized to analyze gene expression. Finally, results were analyzed with the 2−∆∆Ct method with GAPDH and U6 as controls. The primer sequences are displayed as follows: circ_0000376 5′-ATGAAGGCTAGTTTGGAT-3′ and 5′-TAGTCAGGCATAGTGAAG-3′; miR-545-3p 5′-ACACTCCAGCTGGGTCAGCAAACATTTATT-3′ and 5′-TGGTGTCGTGGAGTCG-3′; PDPK1 5′-AGCATCAGTCCGAACCAT-3′ and 5′-GAGTTCCAGGACCACAGC-3′.

2.5 Cell counting kit-8 (CCK-8)

In brief, H522 and A549 cells were cultured in 96-well plates (8 × 103 cells per well) and transfected with siRNAs of circ_0000376, si-NC, miR-545-3p inhibitor, miRNA inhibitor-NC, miR-545-3p mimic, miR-NC, pc-PDPK1, and pc-NC. After 48 h, CCK-8 solution (Abcam, Cambridge, UK) was added to each well. After 3 h, these samples were analyzed with a microplate reader (Thermo Fisher).

2.6 Cell colony formation assay

H522 and A549 cells were seeded in six-well plates and transfected with plasmids and oligonucleotides. After about 2-week culture, the cells were fixed with paraformaldehyde and dyed with crystal violet. Finally, cell colony-forming ability was determined by counting the number of positive colonies.

2.7 Transwell migration and invasion assays

NSCLC cells were mixed with serum-free RPMI-1640 (Procell) or Ham’s F12K (Procell) and then added into the upper chambers, which were coated with Matrigel (Qcbio Science, Shanghai, China) for cell invasion assay. Accordingly, RPMI-1640 containing 15% FBS (Procell) as well as Ham’s F12K possessing 15% FBS were placed into the lower chambers. After 24 h, cells were stained using crystal violet. Finally, cell migratory and invasive capacities were determined under a microscope (Olympus, Tokyo, Japan) with a 100(×) magnification.

2.8 Wound-healing assay

H522 and A549 cells were transfected with plasmids and oligonucleotides. About 2-week culture, cell wounds were created, and FBS-free RPMI-1640 (Procell) and Ham’s F12K (Procell) were added to the culture wells. After 24 h, results were analyzed under a microscope (Olympus).

2.9 Flow cytometry analysis

Cells were harvested after digestion with trypsin (Thermo Fisher) and homogenized in binding buffer (Solarbio, Beijing, China). Afterward, the cells were incubated with Annexin V-FITC (Solarbio) and propidium iodide (PI) (Solarbio), in the dark. These samples were assessed with flow cytometry (Thermo Fisher).

2.10 Glutamate detection assay

H522 and A549 cells were grown in 4.5 cm petri dishes and transfected with plasmids and oligonucleotides. After 48 h, cell samples were lysed with Mammalian Lysis Buffer (Abcam) and then incubated with Enzyme Mixture (Abcam) and nicotinamide adenine dinucleotide phosphate stock solution (Abcam). Finally, these samples were assessed using an enzyme immunoassay analyzer (Thermo Fisher).

2.11 Glutamine determination assay

Briefly, cells were harvested and homogenized in cold Hydrolysis Buffer (Abcam). Insoluble material was removed by centrifugation, and the supernatant was transferred into a clean tube. After that, the samples were purified with perchloric acid (Sigma, St. Louis, MO, USA) and potassium hydroxide, and finally analyzed with an enzyme immunoassay analyzer (Thermo Fisher).

2.12 Western blot analysis

Lysates obtained using NP-40 lysis buffer were loaded onto SDS-PAGE gels (Phygene, Fuzhou, China), and protein bands were electrotransferred onto nitrocellulose membranes. After that, the membranes were blocked with defatted dry milk (Solarbio) and incubated with anti-proliferating cell nuclear antigen (anti-PCNA; 1:1,000), anti-BCL2-associated x protein (anti-Bax; 1:5,000), anti-glutaminase (GLS1; 1:5,000), anti-PDPK1 (1:1,000) as well as anti-GAPDH (1:20,000). The membranes were incubated with secondary antibodies (1:5,000), and protein bands were developed with RapidStep ECL Reagent (Millipore, Bradford, MA, USA). All antibodies were obtained from Abcam Co., Ltd. The intensity of protein bands was quantified by image J software. The relative protein expression was normalized to GAPDH.

2.13 Dual-luciferase reporter assay

The putative binding sites between miR-545-3p and circ_0000376 or PDPK1 were predicted by circular RNA interactome (https://circinteractome.nia.nih.gov/api/v2/mirnasearch? circular_rna_query = hsa_circ_0000376&mirna_query = hsa-miR-545&submit = miRNA + Target + Search) or targetscan online database (http://www.targetscan.org/cgi-bin/targetscan/vert_72/view_gene.cgi? rs = ENST00000441549.3&taxid = 9606&members = miR-545-3p&showcnc = 1&shownc = 1&showncf1 = 1&showncf2 = &subset = 1). Based on the complementary sites, the wild-type (WT) plasmids of circ_0000376 (circ_0000376 WT) and the 3′-untranslated region (3′-UTR) of PDPK1 (PDPK1-3′-UTR WT) and mutant (MUT) plasmids (circ_0000376 MUT and PDPK1-3′-UTR MUT) were built by Geneseed (Guangzhou, China). Subsequently, the above plasmids were mixed with miR-545-3p mimic or miR-NC and transfected into H522 and A549 cells. After 48 h, luciferase activity was analyzed with the Dual-Lucy Assay Kit (Solarbio).

2.14 In vivo assay

The assay was carried out on 12 male BALB/c nude mice (6 weeks, weighting 20 ± 2 g) purchased from Laboratory Animal, Inc. (Beijing, China). 5 × 106 A549 cells were hypodermically injected into the center of the back of mice. After 7 days, tumor volume was measured. After 28 days, the mice were euthanized by cervical dislocation, and the tumor tissues were harvested for further analysis. The Animal Care and Use Committee of Jianhu Clinical Medical College of Yangzhou University approved this study.

2.15 Immunohistochemistry (IHC) assay

IHC assay was conducted to analyze the protein expression of nuclear proliferation marker (Ki67) and PDPK1 in xenografts. In brief, the tissues were cut into sections, fixed with paraformaldehyde (Sigma), dehydrated with ethanol (Millipore), and embedded into paraffin. Next, the sections were dewaxed using xylene (Millipore) and hydrated with ethanol. Then, the primary antibody against Ki67 (1:200; Abcam) or PDPK1 (1:150; Abcam) was employed to incubate the tissues. After being washed by PBS (Solarbio), these sections were reacted with secondary antibodies. Finally, staining images were photographed under a microscope. Meanwhile, for negative controls, the primary antibodies were replaced by PBS under the same conditions.

2.16 Statistical analysis

Data were collected based on three independent duplicate tests and analyzed with SPSS software. Results were shown as mean ± standard deviation. Significant differences were compared with Student’s t-tests, Wilcoxon rank-sum test, or analysis of variance. Fisher’s exact test was used for comparing groups between low and high circ_0000376 expression. P-value <0.05 indicated a significant difference.

3 Results

3.1 circ_0000376 expression was upregulated in NSCLC tissues and cells

circ_0000376 expression was first detected in NSCLC tissues, and the results showed that circ_0000376 was overexpressed in NSCLC tissues compared with paracancerous normal lung tissues (Figure 1a). circ_0000376 expression was significantly increased in H522 and A549 cells when compared with 16HBE cells (Figure 1b). As presented in Table 1, circ_0000376 expression was closely associated with lymph node metastasis, tumor-node-metastasis (TNM) stage, and tumor size of NSCLC patients. Additionally, we found that circ_0000376 expression had no significant difference after treatment of RNase R, but GAPDH expression was dramatically downregulated (Figure 1c), suggesting that circ_0000376 was more stable than linear GAPDH. These data demonstrated that circ_0000376 might be involved in the pathogenesis of NSCLC.

Figure 1 circ_0000376 was upregulated in NSCLC tissues and cells. (a and b) circ_0000376 expression was detected by qRT-PCR in 30 pairs of NSCLC tissues and paracancerous normal lung tissues as well as 16HBE, H522, and A549 cells. (c) RNase R resistance analysis assay showed that circ_0000376 was more stable than linear GAPDH. *P < 0.05.
Figure 1

circ_0000376 was upregulated in NSCLC tissues and cells. (a and b) circ_0000376 expression was detected by qRT-PCR in 30 pairs of NSCLC tissues and paracancerous normal lung tissues as well as 16HBE, H522, and A549 cells. (c) RNase R resistance analysis assay showed that circ_0000376 was more stable than linear GAPDH. *P < 0.05.

Table 1

Association between circ_0000376 expression and clinical features of NSCLC patients

Clinical feature circ_0000376 expression P
High (N = 15) Low (N = 15)
Age >0.05
 ≤50 years 7 8
 >50 years 8 7
Gender
 Female 10 6 >0.05
 Male 5 9
Lymph node metastasis <0.05
 Yes 12 5
 No 3 10
TNM stage <0.05
 I + II 2 11
 III + IV 13 4
Tumor size (cm) <0.05
 ≤3 5 11
 >3 10 4

3.2 circ_0000376 silencing repressed cell proliferation, migration, invasion, and glutamine catabolism and induced cell apoptosis in H522 and A549 cells

The study then analyzed whether circ_0000376 participated in NSCLC process in vitro. Based on the high expression of circ_0000376 in H522 and A549 cells, the small interfering RNA against circ_0000376 was synthesized and its efficiency in downregulating circ_0000376 expression was then determined. Data from qRT-PCR analysis displayed that circ_0000376 expression was dramatically downregulated after transfection of si-circ_0000376 and si-circ_0000376#2 (Figure 2a and Figure S1a). Subsequently, circ_0000376 silencing inhibited H522 and A549 cell viability and colony-forming ability (Figure 2b and c and Figure S1b and c), which suggested that the reduced expression of circ_0000376 could hinder cell proliferation. The migration and invasion of H522 and A549 cells were also inhibited after the downregulation of circ_0000376 (Figure 2d–f and Figure S1d–f). Additionally, the apoptosis of H522 and A549 cells was promoted by the decreased expression of circ_0000376 (Figure 2g and Figure S1g). PCNA is an essential protein in DNA replication and repair and functions by anchoring DNA polymerases and DNA editing enzymes, inhibiting tumor cell proliferation [26]. Bax is a pro-apoptotic protein that possesses 9 α-helices to the mitochondria during cell apoptosis, inhibiting tumor development [27]. circ_0000376 depletion downregulated PCNA protein expression and upregulated Bax protein expression (Figure 2h and i). Further, circ_0000376 knockdown suppressed the production of glutamate and glutamine (Figure 2j and k and Figure S1h and i). In order to further determine the effect of circ_0000376 downregulation on glutamine metabolism, GLS1 protein expression was analyzed in the H522 and A549 cells transfected with si-circ_0000376 and si-NC. Western blot analysis revealed that circ_0000376 absence decreased GLS1 protein level (Figure 2l). Collectively, the above evidence demonstrated that circ_0000376 knockdown inhibited NSCLC cell proliferation, migration, invasion, and glutamine metabolism and induced cell apoptosis.

Figure 2 circ_0000376 absence repressed NSCLC cell tumor properties. (a–l) Both H522 and A549 cells were transfected with si-NC and si-circ_0000376, respectively. (a) Interfering efficiency of si-circ_0000376 was determined by qRT-PCR. (b and c) Cell viability and colony-forming ability were detected by CCK-8 and colony formation assays, respectively. (d and e) Transwell migration and wound-healing assays were performed to analyze the migratory ability of H522 and A549 cells. (f) Transwell invasion assay was carried out to determine the invasive ability of H522 and A549 cells. (g) Cell apoptosis was detected by flow cytometry analysis. (h, i, and l) PCNA, Bax, and GLS1 protein expression were detected by western blot analysis. (j and k) Levels of glutamate and glutamine were determined by glutamate detection and glutamine determination assays, respectively. *P < 0.05.
Figure 2

circ_0000376 absence repressed NSCLC cell tumor properties. (a–l) Both H522 and A549 cells were transfected with si-NC and si-circ_0000376, respectively. (a) Interfering efficiency of si-circ_0000376 was determined by qRT-PCR. (b and c) Cell viability and colony-forming ability were detected by CCK-8 and colony formation assays, respectively. (d and e) Transwell migration and wound-healing assays were performed to analyze the migratory ability of H522 and A549 cells. (f) Transwell invasion assay was carried out to determine the invasive ability of H522 and A549 cells. (g) Cell apoptosis was detected by flow cytometry analysis. (h, i, and l) PCNA, Bax, and GLS1 protein expression were detected by western blot analysis. (j and k) Levels of glutamate and glutamine were determined by glutamate detection and glutamine determination assays, respectively. *P < 0.05.

3.3 circ_0000376 was associated with miR-545-3p in H522 and A549 cells

To disclose the mechanism by which circ_0000376 mediated NSCLC cell tumor properties, the miRNA interacted with circ_0000376 was further searched. As predicted by the circular RNA interactome online database, the circ_0000376 sequence contained the complementary sites of the miR-545-3p sequence (Figure 3a), implying that circ_0000376 might be associated with miR-545-3p. The result exhibited that miR-545-3p mimic was effective in increasing miR-545-3p expression (Figure 3b). As shown in Figure 3c and d, miR-545-3p mimic dramatically repressed the relative luciferase activity of circ_0000376 WT but not that of circ_0000376 MUT. Additionally, we found that miR-545-3p expression was downregulated in NSCLC tissues and H522 and A549 cells in comparison with the matched normal lung tissues and 16HBE cells, respectively (Figure 3e and f). Further, the effects between circ_0000376 silencing and miR-545-3p inhibitor on miR-545-3p expression were determined. As presented in Figure 3g, miR-545-3p inhibitor was effective in decreasing miR-545-3p expression. It was then found that miR-545-3p expression was upregulated after knockdown of circ_0000376, whereas this effect was attenuated by miR-545-3p inhibitor (Figure 3h). All in all, these data demonstrated that circ_0000376 was associated with miR-545-3p in H522 and A549 cells.

Figure 3 circ_0000376 interacted with miR-545-3p in H522 and A549 cells. (a) Binding sites between circ_0000376 and miR-545-3p were predicted by the circular RNA interactome online database. (b and g) Efficiency of miR-545-3p mimic and inhibitor in increasing or decreasing miR-545-3p was determined by qRT-PCR in H522 and A549 cells. (c and d) Dual-luciferase reporter assay was performed to demonstrate that circ_0000376 was associated with miR-545-3p in H522 and A549 cells. (e and f) MiR-545-3p expression was determined by qRT-PCR in 30 pairs of NSCLC tissues and paracancerous normal lung tissues as well as 16HBE, H522, and A549 cells. (h) Impacts between circ_0000376 knockdown and miR-545-3p inhibitor on miR-545-3p expression were disclosed by qRT-PCR in H522 and A549 cells. *P < 0.05.
Figure 3

circ_0000376 interacted with miR-545-3p in H522 and A549 cells. (a) Binding sites between circ_0000376 and miR-545-3p were predicted by the circular RNA interactome online database. (b and g) Efficiency of miR-545-3p mimic and inhibitor in increasing or decreasing miR-545-3p was determined by qRT-PCR in H522 and A549 cells. (c and d) Dual-luciferase reporter assay was performed to demonstrate that circ_0000376 was associated with miR-545-3p in H522 and A549 cells. (e and f) MiR-545-3p expression was determined by qRT-PCR in 30 pairs of NSCLC tissues and paracancerous normal lung tissues as well as 16HBE, H522, and A549 cells. (h) Impacts between circ_0000376 knockdown and miR-545-3p inhibitor on miR-545-3p expression were disclosed by qRT-PCR in H522 and A549 cells. *P < 0.05.

3.4 circ_0000376 regulated H522 and A549 cell proliferation, migration, invasion, apoptosis, and glutamine catabolism by binding to miR-545-3p

Whether circ_0000376 regulated NSCLC cell tumor properties by binding to miR-545-3p was explored in this part. The results showed that circ_0000376 silencing repressed H522 and A549 cell viability and colony-forming ability, whereas these effects were restored by miR-545-3p inhibitor (Figure 4a and b). The repressive impacts of circ_0000376 silencing on the migration and invasion of H522 and A549 cells were also restrained by miR-545-3p inhibitor (Figure 4c–e). Additionally, the promoting effect of circ_0000376 knockdown on cell apoptosis was reversed after transfection of miR-545-3p inhibitor (Figure 4f). In line with the above data, the impacts of circ_0000376 silencing on the protein expression of PCNA and Bax were partially reversed after the downregulation of miR-545-3p (Figure 4g and h). circ_0000376 knockdown-mediated repressive impacts on glutamine and glutamate production as well as GLS1 protein expression were partly abolished by miR-545-3p inhibitor (Figure 4i–k). Thus, these results demonstrated that circ_0000376 could modulate H522 and A549 cell phenotypes by binding to miR-545-3p.

Figure 4 circ_0000376 knockdown repressed NSCLC cell tumor properties by binding to miR-545-3p. (a–k) Both H522 and A549 cells were transfected with si-NC, si-circ_0000376, si-circ_0000376 + miRNA inhibitor-NC, and si-circ_0000376 + miR-545-3p inhibitor, respectively. (a and b) Cell viability and colony-forming ability were detected by CCK-8 assay and colony formation assay, respectively. (c and e) Transwell migration and wound-healing assays were performed to assess the migratory ability of H522 and A549 cells. (d) Transwell invasion assay was conducted to determine the invasive ability of H522 and A549 cells. (f) Cell apoptosis was detected by flow cytometry analysis. (g and h) Western blot analysis was performed to detect the protein expression of PCNA and Bax. (i and j) Levels of glutamine and glutamate were determined by glutamine determination and glutamate detection assays, respectively. (k) GLS1 protein expression was detected by western blot analysis. *P < 0.05.
Figure 4

circ_0000376 knockdown repressed NSCLC cell tumor properties by binding to miR-545-3p. (a–k) Both H522 and A549 cells were transfected with si-NC, si-circ_0000376, si-circ_0000376 + miRNA inhibitor-NC, and si-circ_0000376 + miR-545-3p inhibitor, respectively. (a and b) Cell viability and colony-forming ability were detected by CCK-8 assay and colony formation assay, respectively. (c and e) Transwell migration and wound-healing assays were performed to assess the migratory ability of H522 and A549 cells. (d) Transwell invasion assay was conducted to determine the invasive ability of H522 and A549 cells. (f) Cell apoptosis was detected by flow cytometry analysis. (g and h) Western blot analysis was performed to detect the protein expression of PCNA and Bax. (i and j) Levels of glutamine and glutamate were determined by glutamine determination and glutamate detection assays, respectively. (k) GLS1 protein expression was detected by western blot analysis. *P < 0.05.

3.5 circ_0000376 regulated PDPK1 by interacting with miR-545-3p in H522 and A549 cells

The targetscan online database showed that PDPK1 contained the binding sequence of miR-545-3p (Figure 5a). Dual-luciferase reporter assay showed that miR-545-3p mimic dramatically repressed the relative luciferase activity of PDPK1-3′-UTR WT, whereas it did not repress that of PDPK1-3′-UTR MUT (Figure 5b and c). Subsequently, PDPK1 mRNA expression was substantially upregulated in NSCLC tissues when compared with paracancerous normal lung tissues (Figure 5d). The protein expression of PDPK1 was also increased in NSCLC tissues as well as H522 and A549 cells in comparison with adjacent normal lung tissues and 16HBE cells, respectively (Figure 5e and f). Additionally, PDPK1 expression was significantly increased in H522 and A549 cells transfected with the overexpression plasmid of PDPK1 (Figure 5g), suggesting that pc-PDPK1 was effective in increasing PDPK1 expression. PDPK1 protein expression was downregulated by miR-545-3p mimic, but this impact was attenuated after PDPK1 overexpression (Figure 5h). These results demonstrated that miR-545-3p targeted PDPK1 in H522 and A549 cells. Further, circ_0000376 silencing notably reduced the PDPK1 level, while miR-545-3p inhibitor reversed this impact (Figure 5i), suggesting that circ_0000376 could control PDPK1 expression by binding to miR-545-3p.

Figure 5 circ_0000376 modulated PDPK1 expression by associating with miR-545-3p. (a) Putative binding sites of miR-545-3p for PDPK1 were predicted by the targetscan online database. (b and c) Dual-luciferase reporter assay was performed to demonstrate that miR-545-3p was associated with PDPK1 in H522 and A549 cells. (d) PDPK1 mRNA expression was determined by qRT-PCR in 30 pairs of NSCLC tissues and paracancerous normal lung tissues. (e and f) PDPK1 protein expression was detected by western blot analysis in 30 pairs of NSCLC tissues and paracancerous normal lung tissues as well as 16HBE, H522, and A549 cells. (g) PDPK1 protein expression was determined by western blot analysis in H522 and A549 cells transfected with pc-PDPK1 or pc-NC. (h) Impacts between miR-545-3p mimic and PDPK1 overexpression on PDPK1 protein expression were revealed by western blot analysis in H522 and A549 cells. (i) Effects between circ_0000376 knockdown and miR-545-3p inhibitor on PDPK1 protein expression were determined by western blot analysis in H522 and A549 cells. *P < 0.05.
Figure 5

circ_0000376 modulated PDPK1 expression by associating with miR-545-3p. (a) Putative binding sites of miR-545-3p for PDPK1 were predicted by the targetscan online database. (b and c) Dual-luciferase reporter assay was performed to demonstrate that miR-545-3p was associated with PDPK1 in H522 and A549 cells. (d) PDPK1 mRNA expression was determined by qRT-PCR in 30 pairs of NSCLC tissues and paracancerous normal lung tissues. (e and f) PDPK1 protein expression was detected by western blot analysis in 30 pairs of NSCLC tissues and paracancerous normal lung tissues as well as 16HBE, H522, and A549 cells. (g) PDPK1 protein expression was determined by western blot analysis in H522 and A549 cells transfected with pc-PDPK1 or pc-NC. (h) Impacts between miR-545-3p mimic and PDPK1 overexpression on PDPK1 protein expression were revealed by western blot analysis in H522 and A549 cells. (i) Effects between circ_0000376 knockdown and miR-545-3p inhibitor on PDPK1 protein expression were determined by western blot analysis in H522 and A549 cells. *P < 0.05.

3.6 MiR-545-3p mimic repressed NSCLC cell tumor properties by targeting PDPK1

Given the association between miR-545-3p and PDPK1, we further determined whether PDPK1 participated in miR-545-3p-mediated actions in H522 and A549 cells. Results showed that miR-545-3p suppressed cell viability and colony-forming ability, whereas these effects were reversed after PDPK1 overexpression (Figure 6a and b). The migration and invasion of H522 and A549 cells were also inhibited by miR-545-3p mimic, which was attenuated by PDPK1 overexpression (Figure 6c–e). Additionally, the promoting effect of miR-545-3p mimic on cell apoptosis was restrained by ectopic PDPK1 expression (Figure 6f). MiR-545-3p mimics-mediated impacts on the protein expression of PCNA and Bax were hindered after PDPK1 overexpression (Figure 6g and h). Further, miR-545-3p mimic repressed the production of glutamine and glutamate and downregulated GLS1 protein expression, but these effects were restored by the enforced PDPK1 expression (Figure 6i–k). Thus, these results explained that miR-545-3p could suppress H522 and A549 cell tumor properties by binding to PDPK1.

Figure 6 MiR-545-3p mimic inhibited H522 and A549 cell tumor properties by associating with PDPK1. (a–k) MiR-NC, miR-545-3p mimic, miR-545-3p mimic + pc-NC, and miR-545-3p mimic + pc-PDPK1 were transfected into H522 and A549 cells. (a and b) CCK-8 and colony formation assays were employed to detect cell viability and colony-forming ability, respectively. (c and e) Transwell migration and wound-healing assays were carried out to evaluate the migratory ability of H522 and A549 cells. (d) Transwell invasion assay was conducted to determine the invasive ability of H522 and A549 cells. (f) Cell apoptosis was determined by flow cytometry analysis. (g and h) Protein expression of PCNA and Bax was determined by western blot analysis. (i and j) Levels of glutamine and glutamate were determined by glutamine determination and glutamate detection assays, respectively. (k) GLS1 protein expression was detected by western blot analysis. *P < 0.05.
Figure 6

MiR-545-3p mimic inhibited H522 and A549 cell tumor properties by associating with PDPK1. (a–k) MiR-NC, miR-545-3p mimic, miR-545-3p mimic + pc-NC, and miR-545-3p mimic + pc-PDPK1 were transfected into H522 and A549 cells. (a and b) CCK-8 and colony formation assays were employed to detect cell viability and colony-forming ability, respectively. (c and e) Transwell migration and wound-healing assays were carried out to evaluate the migratory ability of H522 and A549 cells. (d) Transwell invasion assay was conducted to determine the invasive ability of H522 and A549 cells. (f) Cell apoptosis was determined by flow cytometry analysis. (g and h) Protein expression of PCNA and Bax was determined by western blot analysis. (i and j) Levels of glutamine and glutamate were determined by glutamine determination and glutamate detection assays, respectively. (k) GLS1 protein expression was detected by western blot analysis. *P < 0.05.

3.7 circ_0000376 silencing restrained tumor formation in vivo

To validate the effects of circ_0000376 on NSCLC progression in vivo, the study performed the xenograft mouse model assay. The results showed that circ_0000376 knockdown suppressed tumor volume and weight (Figure 7a and b), suggesting that circ_0000376 absence could inhibit tumor formation. Additionally, we found that circ_0000376 expression was decreased in the primary tumors from the sh-circ_0000376 group in comparison with those tumors from the sh-NC group (Figure 7c), implying that sh-circ_0000376 was effective in reducing circ_0000376 expression. Additionally, circ_0000376 knockdown upregulated miR-545-3p expression (Figure 7d) but downregulated PDPK1 protein expression (Figure 7e) in the primary tumors. The number of Ki67 or PDPK1 positive cells was fewer in the sh-circ_0000376 group than in the sh-NC group (Figure 7f and g), suggesting that circ_0000376 knockdown suppressed the protein expression of Ki67 and PDPK1 in the primary tumors. These data demonstrated that circ_0000376 absence inhibited tumor formation by regulating miR-545-3p and PDPK1.

Figure 7 circ_0000376 knockdown inhibited tumor formation. (a and b) Impacts of circ_0000376 absence on tumor volume and weight were revealed. (c and d) Effects of circ_0000376 silencing on the expression of circ_0000376 and miR-545-3p were determined by qRT-PCR in tumor tissues of mice. (e) Influence of circ_0000376 downregulation on PDPK1 protein expression was analyzed by western blot in the tumor tissues of mice. (f and g) Protein expression of Ki67 and PDPK1 was determined by IHC assay. *P < 0.05.
Figure 7

circ_0000376 knockdown inhibited tumor formation. (a and b) Impacts of circ_0000376 absence on tumor volume and weight were revealed. (c and d) Effects of circ_0000376 silencing on the expression of circ_0000376 and miR-545-3p were determined by qRT-PCR in tumor tissues of mice. (e) Influence of circ_0000376 downregulation on PDPK1 protein expression was analyzed by western blot in the tumor tissues of mice. (f and g) Protein expression of Ki67 and PDPK1 was determined by IHC assay. *P < 0.05.

4 Discussion

The special structure of circRNAs makes them resist ribonuclease, suggesting the potential of circRNAs as biological biomarkers for cancers [28]. As reported, NSCLC progression involves the dysregulation of circRNAs [29]. For instance, the increased expression of circ_0074027 contributed to NSCLC cell proliferation and metastasis by interacting with miR-185-3p [30]. Circ_0016760 overexpression promoted NSCLC cell metastatic property and inhibited cell apoptosis by binding to miR-1287 [31]. Circ_0001649 hindered NSCLC cell growth and metastasis by associating with miR-331-3p [32]. Based on the above evidence, we analyzed circRNA(s) related to the pathogenesis of NSCLC to provide a reliable therapeutic target for NSCLC. As a result, we found that circ_0000376 silencing repressed NSCLC cell tumor properties by the miR-545-3p/PDPK1 axis.

In this article, circ_0000376 was overexpressed in NSCLC specimens and cells. circ_0000376 was significantly associated with lymph node metastasis, TNM stage as well as tumor size of NSCLC patients. circ_0000376 absence inhibited NSCLC cell proliferation and metastasis. Additionally, circ_0000376 suppressed tumor formation in vivo. Previous data have suggested that circ_0000376 is augmented in NSCLC tissue samples and promotes NSCLC cell proliferation as well as metastasis [33]. Additionally, it was found that circ_0000376 knockdown reversed hypoxia-induced NSCLC cell proliferation and metastasis [15], implying that circ_0000376 could accelerate cell proliferation and metastasis. Our results were in line with the above data. Beyond that, our evidence also suggested that circ_0000376 absence repressed glutamate and glutamine levels and induced cell apoptosis in NSCLC cells. GLS1 is a cancer-specific glutaminase and catalyzes the glutamine conversion into α-ketoglutarate. Recent work found that GLS1 was overexpressed in most NSCLC cells [34] and that GLS1 depletion reduced NSCLC cell growth [35]. Moreover, GLS1 splice variant GAC was essential for NSCLC cell growth [36]. Herein, we found that circ_0000376 depletion reduced GLS1 protein expression. Considering that circRNA commonly modulated cancer progression by sponging miRNA [37], we further analyzed circ_0000376-associated miRNA. As a result, we confirmed that circ_0000376 bound to miR-545-3p in NSCLC cells.

As reported, miR-545-3p repressed osteogenesis by interacting with LDL receptor related protein 5 [38] and cannabinoid receptor 2 [39]. Besides, miR-545-3p inhibited angiogenesis and metastasis of endometrial carcinoma [40]. In lung cancer, miR-545-3p weakened cell proliferative and metastatic abilities and upregulated cell apoptotic rate [41]. Besides, circ_0072083 sponged miR-545-3p to regulate cisplatin-triggered promotion of NSCLC cell proliferation and metastasis and repression of cell apoptosis [42], suggesting that miR-545-3p inhibited NSCLC cell tumor properties. Similarly, our results showed that miR-545-3p was decreased in NSCLC clinical samples as well as cell lines and that miR-545-3p hindered NSCLC cell tumor properties through the regulation of cell proliferation, metastasis, and apoptosis. Different from the published data, we reported the repressing impact of miR-545-3p on glutamine metabolism for the first time. Additionally, we demonstrated that circ_0000376 regulated NSCLC tumorigenesis by interacting with miR-545-3p.

PDPK1 can activate many downstream factors related to the process of diseases, including cancer [43]. PDPK1 overexpression could neutralize solamargine-reduced NSCLC cell growth [44]. In addition, PDPK1 was associated with the inhibitory effect of Berberine on NSCLC cell proliferation [45]. In this article, PDPK1 was identified as a target of miR-545-3p. A dramatic high expression of PDPK1 was observed in NSCLC clinical samples and cell lines. Additionally, PDPK1 overexpression impaired miR-545-3p mimic-mediated NSCLC cell phenotypes, suggesting that PDPK1 promoted cell proliferation and metastasis and repressed cell apoptosis, which was further proved by Zhou et al. [25] and Li and his colleagues [46]. Beyond that, our data also showed that PDPK1 could promote glutamine catabolism and that miR-545-3p regulated NSCLC tumorigenesis through PDPK1. Further, circ_0000376 regulated PDPK1 expression by interacting with miR-545-3p. Meanwhile, in vivo assay showed that circ_0000376 absence downregulated PDPK1 expression in xenograft.

In addition, in vivo assay related to the effects of miR-545-3p depletion, circ_0000376 overexpression, or PDPK1 depletion on tumor growth can further validate the regulatory effects of the circ_0000376/miR-545-3p/PDPK1 axis on NSCLC cell phenotypes. This issue should be considered when evaluating the present study.

All in all, the present study found that circ_0000376 expression was upregulated in NSCLC tissues and cells and its silencing repressed NSCLC cell tumor properties. Additionally, circ_0000376 absence repressed NSCLC process by binding to miR-545-3p in vitro. MiR-545-3p also regulated NSCLC cell development by targeting PDPK1. Collectively, circ_0000376 regulated NSCLC cell tumor properties by the miR-545-3p/PDPK1 pathway (Figure 8). Our results suggest the potential of circ_0000376 as a novel therapeutic target for NSCLC.

Figure 8 The schematic illustration showing the mechanism underlying circ_0000376 regulating NSCLC cell proliferation, migration, invasion, apoptosis, and glutamine metabolism.
Figure 8

The schematic illustration showing the mechanism underlying circ_0000376 regulating NSCLC cell proliferation, migration, invasion, apoptosis, and glutamine metabolism.

tel: +86 0515 86213711

Acknowledgement

None.

  1. Funding information: None.

  2. Author contributions: Hongjun Guan designed and performed the research; Jinjin Li and Yinfeng Gu analyzed the data; Changpeng Sun wrote the manuscript. All authors read and approved the final manuscript.

  3. Conflict of interest: The authors declare that they have no conflict of interest.

  4. Data availability statement: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.10.3322/caac.21262Search in Google Scholar PubMed

[2] Gu Y, Pei X, Ren Y, Cai K, Guo K, Chen J, et al. Oncogenic function of TUSC3 in non-small cell lung cancer is associated with Hedgehog signalling pathway. Biochim Biophys Acta Mol Basis Dis. 2017;1863(7):1749–60.10.1016/j.bbadis.2017.05.005Search in Google Scholar PubMed

[3] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.10.3322/caac.21551Search in Google Scholar PubMed

[4] Antonia SJ, Balmanoukian A, Brahmer J, Ou SI, Hellmann MD, Kim SW, et al. Clinical activity, tolerability, and long-term follow-up of durvalumab in patients with advanced NSCLC. J Thorac Oncol. 2019;14(10):1794–806.10.1016/j.jtho.2019.06.010Search in Google Scholar PubMed

[5] Li L, Wan K, Xiong L, Liang S, Tou F, Guo S. CircRNA hsa_circ_0087862 acts as an oncogene in non-small cell lung cancer by targeting miR-1253/RAB3D axis. OncoTargets Ther. 2020;13:2873–86.10.2147/OTT.S243533Search in Google Scholar PubMed PubMed Central

[6] Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–91.10.1038/s41576-019-0158-7Search in Google Scholar PubMed

[7] Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–8.10.1038/nature11993Search in Google Scholar PubMed

[8] Verduci L, Strano S, Yarden Y, Blandino G. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669–80.10.1002/1878-0261.12468Search in Google Scholar PubMed PubMed Central

[9] Lu J, Zhang P-Y, Xie J-W, Wang J-B, Lin J-X, Chen Q-Y, et al. Circular RNA hsa_circ_0006848 related to ribosomal protein L6 acts as a novel biomarker for early gastric cancer. Dis Markers. 2019;2019:3863458.10.1155/2019/3863458Search in Google Scholar PubMed PubMed Central

[10] Shen C, Wu Z, Wang Y, Gao S, Da L, Xie L, et al. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. Cancer Med. 2020;9(11):3885–903.10.1002/cam4.3006Search in Google Scholar PubMed PubMed Central

[11] Wang G, Zhang H, Li P. Upregulation of hsa_circRNA_102958 indicates poor prognosis and promotes ovarian cancer progression through miR-1205/SH2D3A axis. Cancer Manag Res. 2020;12:4045–53.10.2147/CMAR.S248560Search in Google Scholar PubMed PubMed Central

[12] Hong W, Xue M, Jiang J, Zhang Y, Gao X. Circular RNA circ-CPA4/let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2020;39(1):149.10.1186/s13046-020-01648-1Search in Google Scholar PubMed PubMed Central

[13] Ju C, Zhou J, Miao H, Chen X, Zhang Q. Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis. BMC Anesthesiol. 2020;20(1):275.10.1186/s12871-020-01179-4Search in Google Scholar PubMed PubMed Central

[14] Peng Z, Xu B, Jin F. Circular RNA hsa_circ_0000376 participates in tumorigenesis of breast cancer by targeting miR-1285-3p. Technol Cancer Res Treat. 2020;19:1533033820928471.10.1177/1533033820928471Search in Google Scholar PubMed PubMed Central

[15] Li C, Liu H, Niu Q, Gao J. Circ_0000376, a novel circRNA, promotes the progression of non-small cell lung cancer through regulating the miR-1182/NOVA2 network. Cancer Manag Res. 2020;12:7635–47.10.2147/CMAR.S258340Search in Google Scholar PubMed PubMed Central

[16] Cui M, Yao X, Lin Y, Zhang D, Cui R, Zhang X. Interactive functions of microRNAs in the miR-23a-27a-24-2 cluster and the potential for targeted therapy in cancer. J Cell Physiol. 2020;235(1):6–16.10.1002/jcp.28958Search in Google Scholar PubMed

[17] Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I. Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci. 2018;75(19):3539–51.10.1007/s00018-018-2877-xSearch in Google Scholar PubMed

[18] Petrek H, Yu AM. MicroRNAs in non-small cell lung cancer: gene regulation, impact on cancer cellular processes, and therapeutic potential. Pharmacol Res Perspect. 2019;7(6):e00528.10.1002/prp2.528Search in Google Scholar PubMed PubMed Central

[19] Cai J, Fang L, Huang Y, Li R, Xu X, Hu Z, et al. Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. Nat Commun. 2017;8:15870.10.1038/ncomms15870Search in Google Scholar PubMed PubMed Central

[20] Liu X, Zhou X, Chen Y, Huang Y, He J, Luo H. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Neoplasma. 2020;67(1):147–57.10.4149/neo_2019_190511N420Search in Google Scholar PubMed

[21] He Z, Liu Y, Xiao B, Qian X. miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression. Biochem Biophys Res Commun. 2015;457(3):235–41.10.1016/j.bbrc.2014.12.094Search in Google Scholar PubMed

[22] Chen S, Lu S, Yao Y, Chen J, Yang G, Tu L, et al. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging. Aging (Albany NY). 2020;12(14):14329–40.10.18632/aging.103472Search in Google Scholar PubMed PubMed Central

[23] Zheng N, Ding X, Sun A, Jahan R. PDK1 activity regulates proliferation, invasion and growth of hemangiomas. Cell Physiol Biochem. 2015;36(5):1903–10.10.1159/000430159Search in Google Scholar PubMed

[24] Maegawa S, Chinen Y, Shimura Y, Tanba K, Takimoto T, Mizuno Y, et al. Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma. Exp Hematol. 2018;59:72–81e2.10.1016/j.exphem.2017.12.006Search in Google Scholar PubMed

[25] Zhou Y, Zheng X, Xu B, Chen L, Wang Q, Deng H, et al. Circular RNA hsa_circ_0004015 regulates the proliferation, invasion, and TKI drug resistance of non-small cell lung cancer by miR-1183/PDPK1 signaling pathway. Biochem Biophys Res Commun. 2019;508(2):527–35.10.1016/j.bbrc.2018.11.157Search in Google Scholar PubMed

[26] Cardano M, Tribioli C, Prosperi E. Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation. Curr Cancer Drug Targets. 2020;20(4):240–52.10.2174/1568009620666200115162814Search in Google Scholar PubMed

[27] Liu Z, Ding Y, Ye N, Wild C, Chen H, Zhou J. Direct activation of bax protein for cancer therapy. Med Res Rev. 2016;36(2):313–41.10.1002/med.21379Search in Google Scholar PubMed PubMed Central

[28] Chen Y, Li C, Tan C, Liu X. Circular RNAs: a new frontier in the study of human diseases. J Med Genet. 2016;53(6):359–65.10.1136/jmedgenet-2016-103758Search in Google Scholar PubMed

[29] Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nature Reviews Genetics. 2016;17(11):679–92.10.1038/nrg.2016.114Search in Google Scholar PubMed PubMed Central

[30] Gao P, Wang Z, Hu Z, Jiao X, Yao Y. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation. J Cell Biochem. 2020;121(3):2632–42.10.1002/jcb.29484Search in Google Scholar PubMed

[31] Li Y, Hu J, Li L, Cai S, Zhang H, Zhu X, et al. Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis. Biochem Biophys Res Commun. 2018;503(3):2089–94.10.1016/j.bbrc.2018.07.164Search in Google Scholar PubMed

[32] Liu T, Song Z, Gai Y. Circular RNA circ_0001649 acts as a prognostic biomarker and inhibits NSCLC progression via sponging miR-331-3p and miR-338-5p. Biochem Biophys Res Commun. 2018;503(3):1503–9.10.1016/j.bbrc.2018.07.070Search in Google Scholar PubMed

[33] Sun H, Chen Y, Fang YY, Cui TY, Qiao X, Jiang CY, et al. Circ_0000376 enhances the proliferation, metastasis, and chemoresistance of NSCLC cells via repressing miR-384. Cancer Biomark. 2020;29(4):463–73.10.3233/CBM-190912Search in Google Scholar PubMed

[34] Lee J-S, Kang JH, Lee S-H, Hong D, Son J, Hong KM, et al. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Cell Death Dis. 2016;7(12):e2511.10.1038/cddis.2016.404Search in Google Scholar PubMed PubMed Central

[35] Lee JS, Kang JH, Lee SH, Lee CH, Son J, Kim SY. Glutaminase 1 inhibition reduces thymidine synthesis in NSCLC. Biochem Biophys Res Commun. 2016;477(3):374–82.10.1016/j.bbrc.2016.06.095Search in Google Scholar PubMed

[36] van den Heuvel AP, Jing J, Wooster RF, Bachman KE. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol Ther. 2012;13(12):1185–94.10.4161/cbt.21348Search in Google Scholar PubMed PubMed Central

[37] Tang Q, Hann SS. Biological roles and mechanisms of circular RNA in human cancers. OncoTargets Ther. 2020;13:2067–92.10.2147/OTT.S233672Search in Google Scholar PubMed PubMed Central

[38] Li L, Qiu X, Sun Y, Zhang N, Wang L. SP1-stimulated miR-545-3p inhibits osteogenesis via targeting LRP5-activated Wnt/beta-catenin signaling. Biochem Biophys Res Commun. 2019;517(1):103–10.10.1016/j.bbrc.2019.07.025Search in Google Scholar PubMed

[39] Hao R, Wang B, Wang H, Huo Y, Lu Y. lncRNA TUG1 promotes proliferation and differentiation of osteoblasts by regulating the miR-545-3p/CNR2 axis. Braz J Med Biol Res. 2020;53(11):e9798.10.1590/1414-431x20209798Search in Google Scholar

[40] Zhong Y, Wang Y, Dang H, Wu X. LncRNA AFAP1-AS1 contributes to the progression of endometrial carcinoma by regulating miR-545-3p/VEGFA pathway. Mol Cell Probes. 2020;53:101606.10.1016/j.mcp.2020.101606Search in Google Scholar PubMed

[41] Sun J, Min H, Yu L, Yu G, Shi Y, Sun J. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer. Anticancer Drugs. 2020;32(1):11–21.10.1097/CAD.0000000000001003Search in Google Scholar PubMed

[42] Li H, Liu F, Qin W. Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis. Cancer Cell Int. 2020;20:78.10.1186/s12935-020-1162-xSearch in Google Scholar PubMed PubMed Central

[43] Gagliardi PA, di Blasio L, Primo L. PDK1: a signaling hub for cell migration and tumor invasion. Biochim Biophys Acta. 2015;1856(2):178–88.10.1016/j.bbcan.2015.07.003Search in Google Scholar PubMed

[44] Tang Q, Zheng F, Liu Z, Wu J, Chai X, He C, et al. Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer. J Cell Mol Med. 2019;23(11):7749–61.10.1111/jcmm.14649Search in Google Scholar PubMed PubMed Central

[45] Zheng F, Wu J, Tang Q, Xiao Q, Wu W, Hann SS. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1. J Cell Mol Med. 2018;22(1):600–12.10.1111/jcmm.13347Search in Google Scholar PubMed PubMed Central

[46] Li C, Zhao W, Pan X, Li X, Yan F, Liu S, et al. LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1. Oncogene. 2020;39(39):6157–71.10.1038/s41388-020-01427-4Search in Google Scholar PubMed

Received: 2022-08-08
Revised: 2022-12-16
Accepted: 2022-12-23
Published Online: 2023-02-16

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
https://doi.org/10.1515/med-2023-0641
Keywords for this article
NSCLC; circ_0000376; miR-545-3p; PDPK1
Creative Commons
BY 4.0

Articles in the same Issue

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 12.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2023-0641/html
Scroll to top button